HighTower Advisors’s LeMaitre Vascular LMAT Stock Holding History

HighTower Advisors’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,815	Closed	-$526K	–	3933
2026 Q1	$526K	Buy	4,815 +581	+14%	+$55.4K	﹤0.01%	2671
2025 Q4	$343K	Sell	4,234 -586	-12%	-$50.4K	﹤0.01%	2939
2025 Q3	$422K	Sell	4,820 -1,010	-17%	-$90.2K	﹤0.01%	2749
2025 Q2	$484K	Sell	5,830 -90	-2%	-$7.52K	﹤0.01%	2552
2025 Q1	$497K	Buy	5,920 +237	+4%	+$22K	﹤0.01%	2467
2024 Q4	$524K	Buy	5,683 +212	+4%	+$20.4K	﹤0.01%	2444
2024 Q3	$512K	Sell	5,471 -462	-8%	-$40K	﹤0.01%	2383
2024 Q2	$493K	Sell	5,933 -10	-0.2%	-$735	﹤0.01%	2338
2024 Q1	$397K	Sell	5,943 -4,019	-40%	-$248K	﹤0.01%	2452
2023 Q4	$572K	Buy	9,962 +219	+2%	+$11.5K	﹤0.01%	2221
2023 Q3	$536K	Buy	+9,743	New	+$577K	﹤0.01%	2194

Other funds holding LMAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

HighTower Advisors's LMAT Position: Q2 2026 in Review

HighTower Advisors sold out of LeMaitre Vascular (LMAT) in Q2 2026, closing a stake of 4,815 shares — an estimated $526K sold.

HighTower Advisors first reported a position in LMAT in Q3 2023 and held it in 11 quarters. The position peaked at $572K in Q4 2023. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

HighTower Advisors reported no remaining LeMaitre Vascular position as of Q2 2026 after selling out during the quarter.
HighTower Advisors sold 4,815 LeMaitre Vascular shares in Q2 2026, an estimated $526K.
HighTower Advisors first reported a position in LeMaitre Vascular in Q3 2023 and held it in 11 quarters.
HighTower Advisors's LeMaitre Vascular position peaked at $572K in Q4 2023.
326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.